Health Care [ 4/12 ] | Health Care Technology [ 70/72 ]
NASDAQ | Common Stock
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.
In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings.
Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions.
The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001.
Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 1, 24 | 0.51 Decreased by -10.53% | 0.14 Increased by +264.29% |
| May 2, 24 | 0.03 Decreased by -92.31% | -0.09 Increased by +133.33% |
| Feb 8, 24 | 0.33 Increased by 0.00% | 0.15 Increased by +120.00% |
| Nov 2, 23 | 0.62 Decreased by -38.00% | 0.47 Increased by +31.91% |
| Aug 1, 23 | 0.57 Decreased by -32.14% | 0.28 Increased by +103.57% |
| May 2, 23 | 0.39 Decreased by -53.01% | 0.07 Increased by +457.14% |
| Feb 28, 23 | 0.33 Decreased by -64.13% | 0.09 Increased by +266.67% |
| Nov 2, 22 | 1.00 Decreased by -7.41% | 0.95 Increased by +5.26% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 298.66 M Decreased by -14.19% | 5.55 M Decreased by -66.90% | Increased by +1.86% Decreased by -61.42% |
| Jun 30, 23 | 298.97 M Decreased by -9.78% | 3.45 M Decreased by -61.95% | Increased by +1.15% Decreased by -57.82% |
| Mar 31, 23 | 290.63 M Decreased by -8.84% | -15.00 M Decreased by -282.64% | Decreased by -5.16% Decreased by -300.36% |
| Dec 31, 22 | 297.67 M Decreased by -4.30% | -28.41 M Decreased by -303.19% | Decreased by -9.54% Decreased by -312.31% |
| Sep 30, 22 | 348.06 M Increased by +17.43% | 16.77 M Decreased by -42.78% | Increased by +4.82% Decreased by -51.28% |
| Jun 30, 22 | 331.39 M Increased by +21.50% | 9.07 M Decreased by -55.60% | Increased by +2.74% Decreased by -63.45% |
| Mar 31, 22 | 318.83 M Increased by +26.60% | 8.21 M Decreased by -41.86% | Increased by +2.58% Decreased by -54.08% |
| Dec 31, 21 | 311.03 M Increased by +24.81% | 13.98 M Decreased by -14.63% | Increased by +4.50% Decreased by -31.60% |